Abstract
Universal Technical Institute will report fiscal results on February 04, 2026 Post Market. This preview consolidates recent financials, segment trends, and consensus-style forecasts to frame revenue, margins, and adjusted EPS expectations, along with the latest majority analyst stance.
Market Forecast
For the current quarter, Universal Technical Institute’s revenue is projected at USD 216.88 million, with forecast year-over-year growth of 11.83%. Forecast EPS is expected at USD 0.14, and forecast EBIT is USD 10.74 million with an estimated year-over-year change of -25.49%. The company’s guidance context implies stable gross profit margin and net margin ranges; however, comparable YoY margin targets are not formally disclosed.
Main business highlights point to steady enrollment and retention driving revenue resilience, while program mix continues to shape margin performance. The most promising segment is the core training programs, projected revenue at USD 216.88 million with an estimated year-over-year increase of 11.83%.
Last Quarter Review
Universal Technical Institute posted revenue of USD 222.44 million, a gross profit margin of 56.42%, net profit attributable to the parent company of USD 18.76 million, a net profit margin of 8.43%, and adjusted EPS of USD 0.34; revenue rose 13.28% year over year while EBIT growth was -3.98% year over year.
A noteworthy highlight was adjusted EPS beating internal and external expectations by USD 0.08, reflecting disciplined cost control against a shifting program portfolio. The main business delivered USD 541.82 million from the “Universal Technical Institute” segment and USD 293.80 million from the “Concorde” segment, sustaining double-digit YoY momentum across core programs.
Current Quarter Outlook
Core Education Programs
The core training programs underpin Universal Technical Institute’s revenue and are directly linked to new student starts, retention, and capacity utilization across campuses. Management has oriented the portfolio toward demand-aligned programs with employer partnerships supporting placement outcomes, which has historically stabilized revenue visibility. This quarter, the forecast points to USD 216.88 million in revenue and EPS of USD 0.14, suggesting a pullback from the prior quarter’s pace but still solid year-over-year expansion of 11.83%. The margin narrative hinges on program mix and instructional efficiency; gross profit margin at 56.42% last quarter sets a high base, and incremental optimization in instruction hours per student could cushion any near-term mix-related headwinds. With EBIT forecast at USD 10.74 million, a year-over-year decline of 25.49%, the focus will be whether operating expenses—marketing, admissions, and compliance—normalize sequentially after a heavier spend period.
Healthcare Programs via Concorde
The Concorde platform remains an important growth contributor, broadening Universal Technical Institute’s exposure to healthcare certifications and degrees. Enrollment trends in allied health and nursing tracks typically correlate with regional labor market needs and clinical site availability, which can introduce quarterly variability in starts and externship throughput. The last quarter’s consolidated revenue strength included contributions from this segment, and the current quarter’s forecast for overall revenue growth indicates continued momentum. Key watch items are clinical capacity constraints and faculty hiring; if those ease, throughput can improve, supporting both revenue and margins. The profitability profile of healthcare programs can differ from automotive and skilled trades, with accreditation requirements and clinical partnerships impacting cost-to-serve; investors will parse whether operating leverage improves quarter over quarter despite the EBIT downdraft implied by the forecast.
Stock Price Drivers This Quarter
The stock’s performance this quarter is likely to be driven by the interplay of enrollment outcomes, segment mix, and operating expense discipline relative to forecasted EBIT. A sequential reset from USD 222.44 million revenue and USD 0.34 EPS last quarter to a forecast of USD 216.88 million and USD 0.14 EPS anchors expectations for lower near-term profitability, magnifying sensitivity to management commentary on admissions funnel health and conversion rates. Margin trajectory will be scrutinized given the prior quarter’s gross margin of 56.42% and net margin of 8.43%; investors will look for signals that gross margin remains within a tight band despite mix. Additionally, any updates on employer partnerships, campus expansions or rationalizations, and regulatory developments affecting program delivery could sway sentiment. If operational spending remains aligned with enrollment growth while preserving instructional quality, the EBIT shortfall implied by projections may be interpreted as transitory.
Analyst Opinions
The majority of recent institutional commentary is cautiously positive, emphasizing sustainable enrollment trends and manageable margin normalization. Several analyst notes highlight the upside from healthcare program integration and improved admissions productivity, while acknowledging near-term EBIT pressure from investment in student services and accreditation requirements. One widely followed sell-side desk anticipates revenue of USD 216.88 million and EPS of USD 0.14 for the quarter, framing the YoY revenue expansion of 11.83% as evidence of underlying demand. Another institutional voice points to last quarter’s adjusted EPS beat and sturdy gross margin of 56.42% as indicators that the company can navigate program mix shifts without compromising unit economics. Taken together, the majority view expects revenue growth to remain intact and margins to normalize through the year as spending calibrates to enrollment cohorts.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.